ArticleClinical kidney journal2022

Cystatin C-based estimated GFR performs best in identifying individuals with poorer survival in an unselected Chinese population: results from the China Health and Retirement Longitudinal Study (CHARLS).

Cheng Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.